Correction: Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

2019 Annals of the Rheumatic Diseases  
Miscellaneous Correction: Comparison of individually tailored versus fixedschedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2) Also, the sentence in the Limitation section of the Discussion "Fixed-schedule infusion-arm patients were more likely to be ANCA-positive at inclusion." should read "Fixed-schedule infusion-arm patients were less likely to be ANCA-positive at inclusion."
doi:10.1136/annrheumdis-2017-212878corr1 fatcat:ohfk3fhmrjdslbufbfkpavlati